DeLorean Artificial Intelligence

Name: DeLorean Artificial Intelligence
Brand: DeLorean Artificial Intelligence

Our flagship medical AI solution, MARTI, is the first #ai in the world to be biologically validated and saves $100PMPM

Est 2019|Valuation $59.5M|Raised $11.4M|4 Ref Customers

LinkedIn 8K|Website|FTEs 23|HQ Palm Beach, Florida, US

MarketsICP Analysis Sales Forecasting

DeLorean Artificial Intelligence screenshot

01Competitive Landscape

Narrative analysis

- Direct competitors and their differentiators - DeLorean AI emphasizes prediction plus recommended actions and offers disease-specific modules and on-premises deployment options. - Innovaccer emphasizes a broad data platform approach with multiple applications and deep integrations. - Health Catalyst emphasizes an analytics platform with a large set of documented case studies and client-validated outcomes. - Feature comparison: where this product excels vs lags behind - Potential strengths - On-premises deployment option for organizations that require greater control over data and infrastructure. - Packaged disease modules and a combined prediction-plus-recommendation framing. - Potential gaps - Public signals of enterprise readiness such as an accessible trust center, published security certification evidence, and detailed integration documentation. - A larger independent validation footprint (peer-reviewed publications, third-party evaluations). - Pricing comparison: value proposition vs alternatives - No public pricing is available; without it, normalizing economic claims against competitors is not possible. Innovaccer and Health Catalyst are typically enterprise-priced and are chosen for platform breadth when organizations plan longer-term transformations. - Market share and adoption trends - Based on public visibility and disclosed funding signals, DeLorean AI appears smaller in scale than the largest competitors with more substantial market presence. Market-share estimates were not available.

	DeLorean AI (MARTI/Medical AI)	Innovaccer	Health Catalyst
Starting Price	Not public	Not public (enterprise)	Not public (enterprise)
Primary Fit	Payers/providers seeking predictive risk and recommended actions, with examples in renal care	Organizations seeking a broad healthcare data platform and multiple operational applications	Organizations focusing on an enterprise analytics foundation with documented improvement programs
Key Strength	Offers on-premises deployment option and packaged disease modules (renal/diabetes/cardiac, etc.)	Platform breadth and extensive EHR integrations	Established analytics pedigree and a sizable catalog of documented case studies and outcomes
Key Weakness	Limited public documentation on security controls and independent end-user reviews; reliance on vendor/partner materials	Implementation complexity and broad scope typical of large platforms	May require significant data maturity and services investment

01Competitive Landscape

Narrative analysis

Direct competitors and their differentiators
- DeLorean AI emphasizes prediction plus recommended actions and offers disease-specific modules and on-premises deployment options.
- Innovaccer emphasizes a broad data platform approach with multiple applications and deep integrations.
- Health Catalyst emphasizes an analytics platform with a large set of documented case studies and client-validated outcomes.
Feature comparison: where this product excels vs lags behind
- Potential strengths
  - On-premises deployment option for organizations that require greater control over data and infrastructure.
  - Packaged disease modules and a combined prediction-plus-recommendation framing.
- Potential gaps
  - Public signals of enterprise readiness such as an accessible trust center, published security certification evidence, and detailed integration documentation.
  - A larger independent validation footprint (peer-reviewed publications, third-party evaluations).
Pricing comparison: value proposition vs alternatives
- No public pricing is available; without it, normalizing economic claims against competitors is not possible. Innovaccer and Health Catalyst are typically enterprise-priced and are chosen for platform breadth when organizations plan longer-term transformations.
Market share and adoption trends
- Based on public visibility and disclosed funding signals, DeLorean AI appears smaller in scale than the largest competitors with more substantial market presence. Market-share estimates were not available.

	DeLorean AI (MARTI/Medical AI)	Innovaccer	Health Catalyst
Starting Price	Not public	Not public (enterprise)	Not public (enterprise)
Primary Fit	Payers/providers seeking predictive risk and recommended actions, with examples in renal care	Organizations seeking a broad healthcare data platform and multiple operational applications	Organizations focusing on an enterprise analytics foundation with documented improvement programs
Key Strength	Offers on-premises deployment option and packaged disease modules (renal/diabetes/cardiac, etc.)	Platform breadth and extensive EHR integrations	Established analytics pedigree and a sizable catalog of documented case studies and outcomes
Key Weakness	Limited public documentation on security controls and independent end-user reviews; reliance on vendor/partner materials	Implementation complexity and broad scope typical of large platforms	May require significant data maturity and services investment